Skip to content

Company information lookup

NEUREN PHARMACEUTICALS LIMITED (NEU)

Biopharmaceutical company with a focus on neurological conditions.

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
NEU 0.115 0% 0.115 0.120 0.120 0.120 0.115 1,443,541

NEUREN PHARMACEUTICALS LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code NEU
Securities
Official Listing Date 3 February, 2005
GICS Industry Group Pharmaceuticals & Biotechnology
Exempt Foreign? No
Internet Address http://www.neurenpharma.com
Registered Office Address At the offices of Lowndes Jordan, Level 15, PWC Tower, 188 Quay Street, AUSTRALIA,
Head Office Telephone +61 3 9092 0480
Head Office Fax +64 9 361 7981
Share Registry LINK MARKET SERVICES LIMITED
LEVEL 1, 333 COLLINS STREET, MELBOURNE, VIC, AUSTRALIA, 3000
Share Registry Telephone 1300 554 474
Directors / Senior Management
Dr Richard Treagus (Executive Chairman)
Mr Larry Glass (Executive Director)
Mr Bruce Hancox (Non Exec. Director)
Mr Trevor Scott (Non Exec. Director)
Mr Jon Pilcher (CFO)
Company Secretary Mr Jon Pilcher
Principal Activities Biopharmaceutical company with a focus on neurological conditions.

NEUREN PHARMACEUTICALS LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
03/12/2014   Appendix 3B 13 PDF
27/11/2014   Investor presentation, 27 November 2014 17 PDF
20/11/2014   Appendix 3B 13 PDF
12/11/2014 asterix Neuren successful in Rett syndrome Phase 2 trial 9 PDF
10/11/2014 asterix Trading Halt 2 PDF
28/10/2014   Appendix 3B 13 PDF
17/10/2014 asterix Appendix 4C - quarterly 5 PDF
09/10/2014   Change of Director's Interest Notice 2 PDF
09/10/2014   Appendix 3B 13 PDF
24/09/2014   Appendix 3B 13 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
19 Dec 2014 0.115 0% 0.120 0.115 1,443,541
18 Dec 2014 0.115 4.55% 0.117 0.115 2,246,757
17 Dec 2014 0.110 0% 0.115 0.110 4,300,896
16 Dec 2014 0.110 -4.35% 0.115 0.110 2,942,002
15 Dec 2014 0.115 -8% 0.120 0.115 2,441,923

* Volume of shares shown represents only those shares traded on ASX.

NEUREN PHARMACEUTICALS LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security NEU. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security NEU

Warrants & Structured Products

No warrants & Structured Products are available over the security NEU